Revance Therapeutics, Inc.
RVNC · NASDAQ
9/30/2024 | 6/30/2024 | 3/31/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $58,585 | $81,728 | $133,159 | $137,329 |
| Short-Term Investments | $125,491 | $150,791 | $144,463 | $116,586 |
| Receivables | $48,263 | $36,088 | $29,887 | $27,676 |
| Inventory | $85,213 | $68,287 | $50,280 | $45,579 |
| Other Curr. Assets | $12,135 | $13,553 | $12,447 | $11,695 |
| Total Curr. Assets | $329,687 | $350,172 | $369,686 | $338,865 |
| Property Plant & Equip (Net) | $76,993 | $92,611 | $87,750 | $90,207 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $7,634 | $8,180 | $8,725 | $9,808 |
| Long-Term Investments | $0 | $5,895 | $5,895 | $6,870 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $47,250 | $37,941 | $36,063 | $32,704 |
| Total NC Assets | $131,877 | $144,627 | $138,433 | $139,589 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $461,564 | $494,799 | $508,119 | $478,454 |
| Liabilities | – | – | – | – |
| Payables | $12,335 | $4,985 | $5,276 | $13,809 |
| Short-Term Debt | $27,363 | $55,720 | $19,252 | $10,854 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $6,329 | $9,610 | $9,784 | $10,737 |
| Other Curr. Liab. | $34,022 | $23,317 | $34,591 | $53,824 |
| Total Curr. Liab. | $80,049 | $93,632 | $68,903 | $89,224 |
| LT Debt | $456,084 | $460,026 | $463,651 | $467,580 |
| Deferred Rev, NC | $0 | $67,968 | $71,403 | $70,419 |
| Deferred Tax Liab, NC | $0 | $36,940 | $38,813 | $0 |
| Other NC Liab. | $88,461 | $2,911 | $2,835 | $2,835 |
| Total NC Liab. | $544,545 | $530,905 | $537,889 | $540,834 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $52,256 | $61,050 | $45,939 | $49,339 |
| Total Liabilities | $624,594 | $624,537 | $606,792 | $630,058 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $105 | $105 | $104 | $88 |
| Retained Earnings | -$2,207,100 | -$2,168,985 | -$2,131,512 | -$2,078,360 |
| AOCI | $0 | -$26 | -$25 | $14 |
| Other Equity | $2,043,965 | $2,039,168 | $2,032,760 | $1,926,654 |
| Total Equity | -$163,030 | -$129,738 | -$98,673 | -$151,604 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $461,564 | $494,799 | $508,119 | $478,454 |
| Net Debt | $424,862 | $434,018 | $349,744 | $341,105 |